Suppr超能文献

体外繁殖的活生物体诱导严重联合免疫缺陷小鼠发生卡氏肺孢子虫肺炎。

Pneumocystis carinii pneumonia in scid mice induced by viable organisms propagated in vitro.

作者信息

Beck J M, Newbury R L, Palmer B E

机构信息

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48105, USA.

出版信息

Infect Immun. 1996 Nov;64(11):4643-7. doi: 10.1128/iai.64.11.4643-4647.1996.

Abstract

Pneumocystis carinii pneumonia remains a major cause of morbidity and mortality in human immunodeficiency virus-infected individuals, despite the widespread use of prophylaxis and the development of new chemotherapeutic agents. The study of P. carinii and of pulmonary host defenses directed against it has been limited by lack of reliable, reproducible methods to obtain pure populations of organisms in useful quantities. While recent success has been achieved with cultures of rat P. carinii organisms, cultures of mouse P. carinii organisms have not been successful. Experiments were performed to determine whether P. carinii organisms derived from mice could be propagated in vitro. Mouse P. carinii organisms, obtained from the lungs of chronically infected athymic mice, were inoculated into spinner flasks containing HEL299 feeder cells seated on microcarrier beads. The numbers of mouse P. carinii organisms increased significantly over 7 days in culture. To test the viability and pathogenicity of these cultured organisms, P. carinii organisms were harvested after 7 days of culture and were inoculated intratracheally into susceptible scid mice. Four weeks after inoculation, scid mice developed uniformly severe P. carinii pneumonia. These studies demonstrate for the first time that mouse P. carinii organisms can be propagated in vitro. Furthermore, cultured mouse P. carinii organisms maintain their pathogenicity in an in vivo model system. This culture system will have important applications in the study of P. carinii biology and in the study of host defenses directed against this important opportunistic pathogen.

摘要

尽管预防性用药已广泛应用且新型化疗药物不断研发,但卡氏肺孢子虫肺炎仍是人类免疫缺陷病毒感染者发病和死亡的主要原因。由于缺乏可靠、可重复的方法来获取大量纯净的卡氏肺孢子虫,对其以及针对它的肺部宿主防御机制的研究受到了限制。虽然最近大鼠卡氏肺孢子虫培养取得了成功,但小鼠卡氏肺孢子虫培养尚未成功。进行了实验以确定源自小鼠的卡氏肺孢子虫是否能在体外繁殖。从慢性感染的无胸腺小鼠肺中获取的小鼠卡氏肺孢子虫接种到装有位于微载体珠上的HEL299饲养细胞的转瓶中。在培养7天期间,小鼠卡氏肺孢子虫数量显著增加。为测试这些培养的病原体的活力和致病性,培养7天后收获卡氏肺孢子虫并经气管内接种到易感的重度联合免疫缺陷小鼠体内。接种4周后,重度联合免疫缺陷小鼠均发生严重的卡氏肺孢子虫肺炎。这些研究首次证明小鼠卡氏肺孢子虫能在体外繁殖。此外,培养的小鼠卡氏肺孢子虫在体内模型系统中保持其致病性。该培养系统在卡氏肺孢子虫生物学研究以及针对这种重要机会性病原体的宿主防御机制研究中将具有重要应用。

相似文献

本文引用的文献

4
The challenge of Pneumocystis carinii culture.卡氏肺孢子虫培养的挑战。
J Eukaryot Microbiol. 1993 Mar-Apr;40(2):188-95. doi: 10.1111/j.1550-7408.1993.tb04902.x.
10
A fifteen-year perspective on the in vitro culture of Pneumocystis carinii.
J Protozool. 1989 Jan-Feb;36(1):23S-24S. doi: 10.1111/j.1550-7408.1989.tb02675.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验